The Bottom Line

Psoriatic arthritis (PsA) is an inflammatory joint condition that affects about 30% of people with psoriasis — roughly 1 million Americans. It causes joint pain, swelling, and stiffness and can permanently damage joints if untreated. In 15–20% of cases, joint symptoms appear before skin symptoms. Starting biologic treatment within 3–6 months of joint symptoms significantly reduces long-term joint damage and disability.

What Is Psoriatic Arthritis?

Psoriatic arthritis (PsA) is a type of inflammatory arthritis that develops in some people who have psoriasis — the chronic skin condition causing thick, scaly, red patches. PsA affects about 30% of people with psoriasis, though it can occasionally occur in people with only minimal skin involvement.

Unlike wear-and-tear arthritis (osteoarthritis), psoriatic arthritis is driven by the immune system attacking your own joints. It can cause permanent joint damage over time, which is why early diagnosis and treatment matter so much. The condition affects men and women equally, usually beginning between ages 40 and 50.

Signs and Symptoms

  • Joint pain, swelling, and tenderness — especially in the morning (morning stiffness lasting 30–60 minutes or more)
  • Swollen fingers or toes that look like sausages (dactylitis) — highly characteristic of PsA
  • Pain at the point where tendons attach to bones (enthesitis) — commonly at the heel or bottom of the foot
  • Lower back or sacroiliac (hip/pelvis) pain — present in up to 42% of patients
  • Nail changes — pitting, lifting of the nail, or thickening (occurs in 80% of PsA patients)
  • Reduced range of motion in affected joints
  • Fatigue — a commonly underreported symptom

Types of Psoriatic Arthritis

PsA can take several forms:

  • Asymmetric oligoarthritis: The most common pattern (40–50%), affecting fewer than 5 joints on different sides of the body
  • Symmetric polyarthritis: Affects both sides similarly (20–30%), resembles rheumatoid arthritis
  • Spondyloarthritis: Involves the spine and sacroiliac joints (5–42% of cases)
  • Distal joint arthritis: Primarily affects the small joints nearest the fingernails and toenails (10–15%), characteristic of PsA
  • Arthritis mutilans: The most severe form (5–10%) — causes destructive bone erosion and can result in significant deformity

Treatment Options

Treatment depends on how many joints are affected and how severe the disease is:

  • NSAIDs: Ibuprofen or naproxen for mild joint pain and stiffness — useful for mild disease but don't prevent joint damage.
  • DMARDs (disease-modifying drugs): Methotrexate, sulfasalazine, and leflunomide reduce inflammation and help slow joint damage in moderate disease.
  • Biologic therapies: The major advance in PsA treatment. TNF-alpha inhibitors (adalimumab, etanercept, certolizumab), IL-17 inhibitors (secukinumab, ixekizumab), and IL-23 inhibitors (guselkumab, risankizumab) work by blocking specific inflammatory proteins. They are highly effective at both controlling symptoms and preventing joint damage.
  • JAK inhibitors: Tofacitinib and upadacitinib are oral targeted therapies effective for moderate-to-severe PsA.
  • Physical therapy: Helps maintain joint function, strength, and range of motion.

Why Early Treatment Matters

PsA can cause permanent, irreversible joint damage even in early stages. Studies show that starting biologic therapy within 3–6 months of joint symptom onset substantially reduces radiographic (X-ray) progression and long-term disability. The longer treatment is delayed, the harder it can be to protect joint health.

When to See a Dermatologist or Rheumatologist

  • You have psoriasis and develop any new joint pain or stiffness
  • Your fingers or toes are swelling in a sausage-like pattern
  • You have heel pain, back pain, or sacroiliac pain alongside psoriasis
  • Your nail changes are worsening (severe pitting, nail detachment)
  • Joint symptoms are limiting your daily activities

Frequently Asked Questions

Does everyone with psoriasis get psoriatic arthritis?

No. About 30% of people with psoriasis develop PsA at some point. However, because joint damage can begin early and silently, people with psoriasis should be alert to any joint symptoms and report them to their dermatologist or rheumatologist promptly.

Can I have psoriatic arthritis without skin symptoms?

Yes — in about 15–20% of cases, joint symptoms appear before the skin rash. In some patients, only minimal or hidden skin involvement (like scalp or nail changes) is present. PsA can be diagnosed based on joint and nail findings even without obvious skin plaques.

Are biologic medicines safe for long-term use?

Biologics have been used for over 20 years in PsA and are generally well tolerated with careful monitoring. They do suppress part of the immune system, so regular check-ups are needed. Your rheumatologist or dermatologist will monitor for any concerns and adjust treatment as needed.

Do I need to see both a dermatologist and a rheumatologist?

Often, yes. Dermatologists manage the skin component of psoriasis while rheumatologists specialize in the joint disease. Many patients receive coordinated care from both, and many modern biologics effectively treat both skin and joint symptoms simultaneously.

References

  1. Coates LC, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations. Arthritis Rheumatol. 2016;68(5):1060-1071.
  2. Gladman DD, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(Suppl 2):ii14-ii17.
  3. Mease PJ, et al. Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis. N Engl J Med. 2015;373(14):1329-1339.

Trusted Resources

Always consult a board-certified dermatologist for personalized advice about your skin condition and treatment options.